In breast cancer cells, interference with SIN3A function induces epigenetic reprogramming and differentiation, and the SIN3A/HDAC complex plays an important role in maintaining sensitivity to chemotherapy in breast cancer [40, 41]. The gene discussed is SIN3A; the disease is breast cancer.